|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: W W CAPITAL CORP, 10-Q, 2000-06-05 |
Next: PROGENICS PHARMACEUTICALS INC, SC 13G/A, 2000-06-05 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED
FROM THE CONSOLIDATED BALANCE SHEETS AND CONSOLIDATED
STATEMENTS OF OPERATIONS FOUND ON PAGES 1, 2 AND 3 OF THE
COMPANY'S FORM 10-Q FOR THE YEAR-TO-DATE, AND IS QUALIFIED IN
ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> JUN-30-2000
<PERIOD-END> MAR-31-2000
<CASH> 253,783
<SECURITIES> 0
<RECEIVABLES> 2,570,793
<ALLOWANCES> (147,500)
<INVENTORY> 4,574,651
<CURRENT-ASSETS> 7,520,064
<PP&E> 4,778,386
<DEPRECIATION> (2,910,333)
<TOTAL-ASSETS> 9,474,997
<CURRENT-LIABILITIES> 3,761,196
<BONDS> 2,733,448
0
0
<COMMON> 55,406
<OTHER-SE> 2,878,316
<TOTAL-LIABILITY-AND-EQUITY> 9,474,997
<SALES> 14,465,557
<TOTAL-REVENUES> 14,465,557
<CGS> 11,631,550
<TOTAL-COSTS> 11,631,550
<OTHER-EXPENSES> 2,249,624
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> (226,918)
<INCOME-PRETAX> 418,504
<INCOME-TAX> 100,000
<INCOME-CONTINUING> 318,504
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 318,504
<EPS-BASIC> .06
<EPS-DILUTED> .06
</TABLE>
|
|